US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 8.060
  • +0.090+1.13%
Trading Dec 12 13:02 ET
157.42MMarket Cap-5.53P/E (TTM)

Actuate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-62.27%-9.15M
47.74%-2.67M
2.08%-5.25M
-21.53%-21.63M
-5.51M
-5.64M
-5.12M
-5.36M
-17.79M
Net income from continuing operations
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
---7.61M
---6.34M
---5.52M
---5.27M
---20.16M
Operating gains losses
-3,085.05%-537.19K
777.27%440.34K
4,655.54%232.52K
318.22%79.82K
--51.6K
---16.87K
--50.19K
---5.1K
---36.58K
Other non cash items
-32.59%3.41K
0.28%5.08K
-82.16%5.08K
169.39%43.64K
--5.06K
--5.06K
--5.06K
--28.45K
--16.2K
Change In working capital
-891.51%-4.4M
852.25%2.66M
1,376.66%2.36M
48.56%2.57M
--1.92M
--556.25K
--279.67K
---185.07K
--1.73M
-Change in prepaid assets
-37,520.15%-541.35K
---78.2K
-1,679.92%-82.87K
87.51%-3.16K
---6.97K
---1.44K
--0
--5.25K
---25.3K
-Change in payables and accrued expense
-792.39%-3.86M
880.22%2.74M
1,385.02%2.45M
46.60%2.58M
--1.93M
--557.69K
--279.67K
---190.31K
--1.76M
Cash from discontinued investing activities
Operating cash flow
-62.27%-9.15M
47.74%-2.67M
2.08%-5.25M
-21.53%-21.63M
---5.51M
---5.64M
---5.12M
---5.36M
---17.79M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
22.32M
-42.73%957.04K
76.88%4.36M
-78.53%4.13M
0
0
1.67M
2.46M
19.26M
Net issuance payments of debt
--0
--1M
--4.5M
----
----
--0
--0
--0
----
Net preferred stock issuance
--0
--0
--0
-78.53%4.13M
--0
--0
--1.67M
--2.46M
--19.26M
Net other financing activities
---1.64M
---42.96K
---142.77K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--22.32M
-42.73%957.04K
76.88%4.36M
-78.53%4.13M
--0
--0
--1.67M
--2.46M
--19.26M
Net cash flow
Beginning cash position
-97.51%351.71K
-88.22%2.07M
-85.53%2.96M
7.70%20.45M
--8.47M
--14.11M
--17.55M
--20.45M
--18.99M
Current changes in cash
333.61%13.17M
50.17%-1.72M
69.25%-890.35K
-1,296.78%-17.49M
---5.51M
---5.64M
---3.45M
---2.9M
--1.46M
End cash Position
59.65%13.52M
-97.51%351.71K
-88.22%2.07M
-85.53%2.96M
--2.96M
--8.47M
--14.11M
--17.55M
--20.45M
Free cash flow
-62.27%-9.15M
47.74%-2.67M
2.08%-5.25M
-21.53%-21.63M
---5.51M
---5.64M
---5.12M
---5.36M
---17.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -62.27%-9.15M47.74%-2.67M2.08%-5.25M-21.53%-21.63M-5.51M-5.64M-5.12M-5.36M-17.79M
Net income from continuing operations 5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M---7.61M---6.34M---5.52M---5.27M---20.16M
Operating gains losses -3,085.05%-537.19K777.27%440.34K4,655.54%232.52K318.22%79.82K--51.6K---16.87K--50.19K---5.1K---36.58K
Other non cash items -32.59%3.41K0.28%5.08K-82.16%5.08K169.39%43.64K--5.06K--5.06K--5.06K--28.45K--16.2K
Change In working capital -891.51%-4.4M852.25%2.66M1,376.66%2.36M48.56%2.57M--1.92M--556.25K--279.67K---185.07K--1.73M
-Change in prepaid assets -37,520.15%-541.35K---78.2K-1,679.92%-82.87K87.51%-3.16K---6.97K---1.44K--0--5.25K---25.3K
-Change in payables and accrued expense -792.39%-3.86M880.22%2.74M1,385.02%2.45M46.60%2.58M--1.93M--557.69K--279.67K---190.31K--1.76M
Cash from discontinued investing activities
Operating cash flow -62.27%-9.15M47.74%-2.67M2.08%-5.25M-21.53%-21.63M---5.51M---5.64M---5.12M---5.36M---17.79M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 22.32M-42.73%957.04K76.88%4.36M-78.53%4.13M001.67M2.46M19.26M
Net issuance payments of debt --0--1M--4.5M----------0--0--0----
Net preferred stock issuance --0--0--0-78.53%4.13M--0--0--1.67M--2.46M--19.26M
Net other financing activities ---1.64M---42.96K---142.77K------------------------
Cash from discontinued financing activities
Financing cash flow --22.32M-42.73%957.04K76.88%4.36M-78.53%4.13M--0--0--1.67M--2.46M--19.26M
Net cash flow
Beginning cash position -97.51%351.71K-88.22%2.07M-85.53%2.96M7.70%20.45M--8.47M--14.11M--17.55M--20.45M--18.99M
Current changes in cash 333.61%13.17M50.17%-1.72M69.25%-890.35K-1,296.78%-17.49M---5.51M---5.64M---3.45M---2.9M--1.46M
End cash Position 59.65%13.52M-97.51%351.71K-88.22%2.07M-85.53%2.96M--2.96M--8.47M--14.11M--17.55M--20.45M
Free cash flow -62.27%-9.15M47.74%-2.67M2.08%-5.25M-21.53%-21.63M---5.51M---5.64M---5.12M---5.36M---17.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+1.29%
Microsoft
MSFT
+1.16%
Cisco
CSCO
+1.14%
Apple
AAPL
+0.89%
Alibaba
BABA
+0.31%

Unlock the Full List

Investment Theme Recent IPOs
Recent IPOs
Intraday-0.39%